Cetirizine modifies quality of life and symptoms in children with seasonal allergic rhinitis: a pilot study.


Journal

Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064

Informations de publication

Date de publication:
17 06 2020
Historique:
received: 29 05 2020
accepted: 17 06 2020
entrez: 8 3 2021
pubmed: 9 3 2021
medline: 4 6 2021
Statut: epublish

Résumé

Background and aim Seasonal allergic rhinitis (SAR) is a common disease in childhood that is characterized by bothersome symptoms and impaired quality of life (QoL). As histamine is the pivotal pathogenic mediator in SAR, antihistamines are the first-line option in the treatment. Cetirizine is a well-known effective antihistamine. This real-life pilot study aimed to investigate the effectiveness of a 4-week continuous cetirizine treatment in a group of Italian children with SAR. Methods Total symptom score (TSS) and the Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ) were assessed at baseline and the end of the treatment. Results Cetirizine significantly improved QoL (in all domains) and symptom severity (p<0.001 for both). Conclusions The present preliminary study showed that a 4-week cetirizine treatment was able to improve QoL significantly. Cetirizine treatment also significantly reduced symptom severity in Italian children with SAR and was safe.

Identifiants

pubmed: 33682837
doi: 10.23750/abm.v92i1.9948
pmc: PMC7975941
doi:

Substances chimiques

Cetirizine YO7261ME24

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2021003

Références

Clin Exp Allergy. 2007 Oct;37(10):1528-35
pubmed: 17883732
Int Arch Allergy Immunol. 2004 May;134(1):34-40
pubmed: 15051938
J Allergy Clin Immunol. 2019 Nov;144(5):1143-1148
pubmed: 31703761
Clin Exp Allergy. 2003 Mar;33(3):351-8
pubmed: 12614450
Allergy. 2020 Sep;75(9):2402-2405
pubmed: 32418233
Allergy. 2018 Sep;73(9):1851-1859
pubmed: 29791010
Allergy Asthma Clin Immunol. 2019 Oct 1;15:61
pubmed: 31582993
Ann Allergy Asthma Immunol. 2001 Sep;87(3):222-6
pubmed: 11570619
Multidiscip Respir Med. 2019 Dec 6;14:40
pubmed: 31827796
Allergy Asthma Proc. 2017 May 1;38(3):222-230
pubmed: 28441993
Allergy. 2007 Sep;62(9):1087-90
pubmed: 17578494
Qual Life Res. 1996 Feb;5(1):35-46
pubmed: 8901365
Curr Opin Allergy Clin Immunol. 2016 Jun;16(3):250-6
pubmed: 27031675
Clin Pediatr (Phila). 2002 Nov-Dec;41(9):687-96
pubmed: 12462319
Otolaryngol Head Neck Surg. 2005 Sep;133(3):429-35
pubmed: 16143195
N Engl J Med. 2016 Dec 8;375(23):2293-2297
pubmed: 27959688

Auteurs

Marco Benazzo (M)

University of Pavia. m.benazzo@smatteo.pv.it.

Salvatore Leonardi (S)

University of Catania. leonardi@unict.it.

Angelo Corsico (A)

University of Pavia. corsico@unipv.it.

Amelia Licari (A)

University of Pavia. a.licari@smatteo.pv.it.

Michele Miraglia Del Giudice (M)

University of Campania. michele.miragliadelgiudice@unicampania.it.

Diego Peroni (D)

University of Pisa. diego.peroni@unipi.it.

Carmelo Salpietro (C)

University of Messina. carmelo.salpietro@unime.it.

Gian Luigi Marseglia (GL)

University of Pavia. gl.marseglia@smatteo.pv.it.

Giorgio Ciprandi (G)

. gio.cip@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH